Research Highlights

Nature Clinical Practice Nephrology (2006) 2, 121
doi:10.1038/ncpneph0088  

Renal apoA-I amyloidosis is a rare disease that is difficult to recognize

Pippa Murdie

This article has no abstract so we have provided the first paragraph of the full text.

Mutations in apolipoprotein A-I (apoA-I) result in deposition of amyloid fibrils, predominantly in the liver, kidney and heart, and cause a rare, late-onset, autosomal dominant form of amyloidosis. In a paper published in the Journal of the American Society of Nephrology, Gregorini et al. add to their previous data regarding renal involvement in patients with hereditary apoA-I amyloidosis associated with a Leu75right arrowPro heterozygous mutation.

Full text of this article is available with one of the following:
  1. Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
  2. Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
  3. 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
  4. Site licence Learn more about institutional site licences

Current Subscribers

Please log in to access the full text article using the login box at the top of the page.



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Sand in the sheets

Nature Medicine News and Views (01 Feb 1995)

Sand in the sheets

Nature Medicine News and Views (01 Feb 1995)

Extra navigation

.